Notice of Participation of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in PA-21-110 Pilot and Feasibility Studies in Preparation for Substance Use Preventions Trials (R34 Clinical Trial Optional)
Notice Number:
NOT-AA-21-019

Key Dates

Release Date:

April 6, 2021

Related Announcements

PA-21-110 - Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials

Issued by

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Purpose

This Notice informs potential applicants that the National Institute on Alcohol Abuse and Alcoholism (NIAAA) is participating, effective immediately, in PA-21-110 "Pilot and Feasibility Studies in Preparation for Substance Use Preventions Trials (R34 Clinical Trial Optional)”.

The following text has been added to reflect NIAAA's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.273

Part 2. Section I. Funding Opportunity Description

Institute Interests

NIAAA

NIAAA supports research relevant to the study and development of intervention to reduce high intensity drinking, simultaneous alcohol and drug use, drug and alcohol use related intentional and unintentional injuries, accidents, motor vehicle crashes, opioid overdoses and violence, including suicide, interpersonal violence, and community violence, as well as studies of interventions focused on college age (including those not in college) and underage populations. NIAAA encourages research on both individual and environmental alcohol strategies (e.g., prevention intervention studies that incorporate both strategies to reduce risky and impaired driving). NIAAA also is interested in testing prevention interventions for difficult to reach populations (e.g., at-risk and stigmatized populations, underserved, and individuals in rural settings, etc.). Investigators who conduct original and innovative basic biomedical, social, behavioral, clinical, or population-based research directed toward eliminating health disparities are invited to apply to this FOA.

Research shows that diverse teams working together outperform homogenous teams. Scientists and trainees from diverse backgrounds and with different life experiences bring different perspectives, creativity, and individual enterprise to address complex scientific problems. Diverse teams of scientists will lead the way to develop more innovative inclusive research that will more broadly enhance public health. Fostering diversity by addressing underrepresentation in the scientific research workforce is a key component of the NIH strategy to identify, develop, support, and maintain the quality of our scientific workforce. It is expected that research programs will include a diverse group of scientists, including individuals from underrepresented backgrounds as per NOT OD 20-031(Notice of NIH's Interest in Diversity). NIAAA is especially interested in enhancing representation from racial, ethnic and gender minorities and early-stage investigators.

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

Beverly A Ruffin, PhD
National Institute on Alcoholism and Alcohol Abuse (NIAAA)
Telephone: 301-443-0281
Email: ruffinb@mail.nih.gov

Financial/Grants Management Contact(s)

Judy Fox
National Institute on Alcoholism and Alcohol Abuse (NIAAA)
Telephone: 301-443-4704
jfox@mail.nih.gov

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Beverly A Ruffin, PhD
National Institute on Alcoholism and Alcohol Abuse (NIAAA)
Telephone: 301-443-0281
Email: ruffinb@mail.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices